Literature DB >> 33012523

Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.

Hongyu Zhou1, Lihua Chen2, Yajie Lei1, Tianjiao Li3, Haoran Li4, Xi Cheng5.   

Abstract

To explore the prognostic value of tumor mutation burden (TMB) and its correlation with immune infiltrates in endometrial cancer. Transcriptome and somatic mutation profiles of Uterine Corpus Endometrial Carcinoma (UCEC) were downloaded from TCGA database. Somatic mutations were analyzed by "maftools" and visualized in waterfall plot. We calculated TMB of each patients and divided all patients into the high-TMB group and the low-TMB group by the median threshold. Survival analysis and Wilcoxon test were used to investigate the prognostic value of TMB and its association with clinical variables. Differentially expressed genes (DEGs) were identified in 2 TMN groups and functional analysis was performed to find out significant biological pathways. A TMB-related signature was conducted by multivariate analysis, receiver operating characteristic (ROC) curve was performed to predict accuracy of the model, meanwhile, a validation cohort from Fudan University Shanghai Cancer Center (FUSCC) was obtained to verify the signature. Then we estimated association between TMB and immune infiltrates by CIBERSORT algorithm and figured out prognostic immune cells of UCEC in TIMER database. Total 575 samples including 25 normal tissues and 552 tumor samples were enrolled from TCGA database. PTEN mutations accounted for the most and single nucleotide polymorphism and C>T transitions were most frequent forms of somatic mutations in UCEC. The low-TMB group possessed worse survival than the high-TMB group (P = 0.004). DEGs in 2 TMB groups were mostly enriched in adaptive immune response and immunoglobulin/immune receptor component. A TMB-related signature consisting of GFAP, EDN3, CXCR3, PLXNA4, SST presented good predictability with area under the curve (AUC) = 0.686. In FUSCC validation cohort, the high-risk group possessed worse survival outcome than the low-risk group (P = 0.015). Immune infiltrates was correlated to survival in UCEC and low TMB were associated with less immune infiltrates, which suggested poor immune response. TMB was not only related to overall survival but also immune infiltrates in UCEC. The TMB-related signature (GFAP, EDN3, CXCR3, PLXNA4, SST) had good predictability for overall survival in endometrial cancer. Our study might have some merits in elucidating potential mechanism of TMB and immune infiltrates in UCEC and providing guidance of immunotherapy for endometrial cancer.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Endometrial cancer; Immune infiltrate; Survival; TCGA; Tumor mutation burden

Mesh:

Substances:

Year:  2020        PMID: 33012523     DOI: 10.1016/j.currproblcancer.2020.100660

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  8 in total

1.  Identification of molecular subtypes premised on the characteristics of immune infiltration of endometrial cancer.

Authors:  Cong Liu; Yan Zhang; Chen Hang
Journal:  Ann Transl Med       Date:  2022-03

2.  Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.

Authors:  Siqin Zhang; Shaoyong Chen; Yuchen Wang; Yuxiang Zhan; Jiarui Li; Xiaolin Nong; Biyun Gao
Journal:  Front Genet       Date:  2021-12-17       Impact factor: 4.599

3.  Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC.

Authors:  Jinhui Liu; Rui Geng; Senmiao Ni; Lixin Cai; Sheng Yang; Fang Shao; Jianling Bai
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-25       Impact factor: 8.886

4.  N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma.

Authors:  Jinhui Liu; Rui Geng; Zihang Zhong; Yixin Zhang; Senmiao Ni; Wen Liu; Mulong Du; Jianling Bai
Journal:  Oxid Med Cell Longev       Date:  2022-07-31       Impact factor: 7.310

5.  Upregulated keratin 15 links to the occurrence of lymphovascular invasion, stromal cervical invasion as well as unfavorable survival profile in endometrial cancer patients.

Authors:  Hongxiang Yang; Aijing Li; Aili Li; Fei Zhao; Tongyan Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

6.  An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.

Authors:  Shanshan Tang; Yiyi Zhuge
Journal:  Biomed Eng Online       Date:  2021-06-30       Impact factor: 2.819

7.  Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.

Authors:  Jinzhi Lai; Tianwen Xu; Hainan Yang
Journal:  BMC Cancer       Date:  2022-03-25       Impact factor: 4.430

8.  Pan-cancer analysis of m5C regulator genes reveals consistent epigenetic landscape changes in multiple cancers.

Authors:  Yuting He; Xiao Yu; Menggang Zhang; Wenzhi Guo
Journal:  World J Surg Oncol       Date:  2021-07-29       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.